Entry ID,Ligand,Value,Symbol,Type,Unit,PDB ID,Title,Structure Title,Stucture Keywords,Gene Name,EC Number,Annotation Identifier,Entity ID,Entry Id (Polymer Entity Identifiers),Target Protein,Accession Code(s),Database Name,Ligand Formula,Ligand MW,Ligand ID,Ligand Name,Ligand SMILES,Entity ID
7UAD,,,,,,7UAD,PTPN2/N1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity,Crystal structure of human PTPN2 with inhibitor ABBV-CLS-484,SIGNALING PROTEIN/INHIBITOR,"PTPN2, PTPT",3.1.3.48,"GO:0005737, GO:0005829, GO:0005783, GO:0005793, GO:0005654, GO:0005634, GO:0005886, GO:0005178, GO:0004726, GO:0019901, GO:0004725, GO:0030971, GO:0097677, GO:0019905, GO:0030183, GO:0030218, GO:0042593, GO:0008286, GO:0008285, GO:0050922, GO:0042059, GO:0070373, GO:0050728, GO:0046627, GO:0060336, GO:1902206, GO:1902215, GO:0070104, GO:0010888, GO:1902227, GO:0045650, GO:2000587, GO:1902233, GO:0061099, GO:0046426, GO:0050860, GO:0000122, GO:0010804, GO:0060339, GO:0042532, GO:0035335, GO:1902237, GO:0045722, GO:1903899, GO:1902202, GO:0060334, GO:0030217, IPR029021, IPR000242, IPR012265, IPR016130, IPR003595, IPR000387, P17706",1,7UAD,wlidetype,P17706,UniProt,C17 H24 F N3 O4 S,385.454,M5R,"5-{(7R)-1-fluoro-3-hydroxy-7-[(3-methylbutyl)amino]-5,6,7,8-tetrahydronaphthalen-2-yl}-1lambda~6~,2,5-thiadiazolidine-1,1,3-trione",CC(C)CCNC1CCc2cc(c(c(c2C1)F)N3CC(=O)NS3(=O)=O)O,2
7UMO,,,,,,7UMO,Insulin sensitization by small molecules enhancing GLUT4 translocation.,Structure of Unc119-inhibitor complex.,TRANSPORT PROTEIN,"UNC119, RG4",,"GO:0005813, GO:0005829, GO:0045171, GO:0051233, GO:0000922, GO:0045202, GO:0008289, GO:0007268, GO:0006897, GO:0042953, GO:0000281, GO:2001287, GO:1900186, GO:0007399, GO:0007602, GO:0061098, GO:0007601, IPR014756, IPR008015, IPR037036, IPR032977, Q13432",1,7UMO,wlidetype,Q13432,UniProt,C16 H18 Cl2 N2 O,325.233,NT6,"(3s,5s,7s)-N-(4,5-dichloropyridin-2-yl)adamantane-1-carboxamide",c1c(c(cnc1NC(=O)C23CC4CC(C2)CC(C4)C3)Cl)Cl,2
7Y0B,,,,,,7Y0B,Crystal structure of human short-chain acyl-coA dehydrogenase,Crystal structure of human short-chain acyl-CoA dehydrogenase,OXIDOREDUCTASE,ACADS,1.3.8.1,"GO:0005813, GO:0005759, GO:0005739, GO:0005654, GO:0005634, GO:0003995, GO:0004085, GO:0050660, GO:0046359, GO:0006635, GO:0033539, IPR006089, IPR006091, IPR046373, IPR036250, IPR009075, IPR013786, IPR037069, IPR009100, P16219",1,7Y0B,wlidetype,P16219,UniProt,C23 H27 Cl O7,450.909,7R3,"(2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol",c1cc(ccc1Cc2cc(ccc2Cl)C3C(C(C(C(O3)CO)O)O)O)OC4CCOC4,3
7Y1Y,,,,,,7Y1Y,Structural Basis for the Enhanced Infectivity and Immune Evasion of Omicron Subvariants.,S-ECD (Omicron BA.2) in complex with PD of ACE2,VIRAL PROTEIN/HYDROLASE,"S, 2",,"GO:0044173, GO:0020002, GO:0016020, GO:0019031, GO:0055036, GO:0046789, GO:0042802, GO:0075509, GO:0039654, GO:0019064, GO:0061025, GO:0046598, GO:0019065, GO:0046813, GO:0039587, GO:0039502, GO:0046718, GO:0019058, IPR032500, IPR042578, IPR043607, IPR043473, IPR043002, IPR044341, IPR018548, IPR044366, IPR036326, IPR002552, IPR044873, IPR044874, P0DTC2",1,7Y1Y,mutant,P0DTC2,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,4
7Y1Z,,,,,,7Y1Z,Structural Basis for the Enhanced Infectivity and Immune Evasion of Omicron Subvariants.,S-ECD (Omicron BA.3) in complex with three PD of ACE2,VIRAL PROTEIN/HYDROLASE,"S, 2",,"GO:0044173, GO:0020002, GO:0016020, GO:0019031, GO:0055036, GO:0046789, GO:0042802, GO:0075509, GO:0039654, GO:0019064, GO:0061025, GO:0046598, GO:0019065, GO:0046813, GO:0039587, GO:0039502, GO:0046718, GO:0019058, IPR032500, IPR042578, IPR043607, IPR043473, IPR043002, IPR044341, IPR018548, IPR044366, IPR036326, IPR002552, IPR044873, IPR044874, P0DTC2",1,7Y1Z,mutant,P0DTC2,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,4
7YAN,,,,,,7YAN,UDP-glucuronosyltransferase2B17 C-terminal domain,UDP-glucuronosyltransferase2B17 C-terminal domain,TRANSFERASE,UGT2B17,2.4.1.17,"GO:0005789, GO:0016020, GO:0015020, GO:0052695, GO:0008210, GO:0008202, GO:0006805, IPR002213, IPR035595, O75795",1,7YAN,wlidetype,O75795,UniProt,C4 H6 O6,150.087,TLA,L(+)-TARTARIC ACID,C(C(C(=O)O)O)(C(=O)O)O,2
7YHW,,,,,,7YHW,Structural basis for receptor binding and broader interspecies receptor recognition of currently circulating Omicron sub-variants.,Cryo-EM structure of SARS-CoV-2 Omicron BA.2.12.1 RBD in complex with human ACE2 (local refinement),HYDROLASE/VIRAL PROTEIN,"S, 2","3.4.17.23, 3.4.17","GO:0044173, GO:0020002, GO:0016020, GO:0019031, GO:0055036, GO:0046789, GO:0042802, GO:0075509, GO:0039654, GO:0019064, GO:0061025, GO:0046598, GO:0019065, GO:0046813, GO:0039587, GO:0039502, GO:0046718, GO:0019058, IPR032500, IPR042578, IPR043607, IPR043473, IPR043002, IPR044341, IPR018548, IPR044366, IPR036326, IPR002552, IPR044873, IPR044874, P0DTC2",2,7YHW,mutant,P0DTC2,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,5
7YIU,,,,,,7YIU,Ceramide sensing by human SPT-ORMDL complex for establishing sphingolipid homeostasis.,Cryo-EM structure of the C6-ceramide-bound SPT-ORMDL3 complex,TRANSFERASE/inhibitor,"SPTSSA, C14orf147, SSSPTA",,"GO:0005783, GO:0005789, GO:0017059, GO:0004758, GO:0046513, GO:0008104, GO:0030148, GO:0046512, IPR024512, Q969W0, Generic PDBTM",4,7YIU,wlidetype,Q969W0,UniProt,C24 H47 N O3,397.635,6CM,"N-((E,2S,3R)-1,3-DIHYDROXYOCTADEC-4-EN-2-YL)HEXANAMIDE",CCCCCCCCCCCCCC=CC(C(CO)NC(=O)CCCCC)O,7
7YIV,,,,,,7YIV,The structural pathology for hypophosphatasia caused by malfunctional tissue non-specific alkaline phosphatase.,The Crystal Structure of Human Tissue Nonspecific Alkaline Phosphatase (ALPL) at Basic pH,HYDROLASE,ALPL,"3.1.3.1, 3.9.1.1","GO:0070062, GO:0031012, GO:0005576, GO:0016020, GO:0005758, GO:0031966, GO:0005886, GO:0043262, GO:0004035, GO:0016887, GO:0005509, GO:0004427, GO:0050187, GO:0052732, GO:0033883, GO:0016462, GO:0030282, GO:0055074, GO:0019725, GO:0071407, GO:0071529, GO:0016311, GO:0003006, GO:0001958, GO:0140651, GO:0140928, GO:0001649, GO:0055062, GO:0120162, GO:0042822, GO:0046677, GO:0051384, GO:0032868, GO:0032496, GO:0036005, GO:1904383, GO:0034516, GO:0033280, GO:0001501, IPR001952, IPR018299, IPR017850, P05186",1,7YIV,wlidetype,P05186,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,3
7YIY,,,,,,7YIY,Ceramide sensing by human SPT-ORMDL complex for establishing sphingolipid homeostasis.,Cryo-EM structure of SPT-ORMDL3 complex,TRANSFERASE/INHIBITOR COMPLEX,"SPTLC1, LCB1",2.3.1.50,"GO:0005783, GO:0005789, GO:0017059, GO:0035339, GO:0030170, GO:0004758, GO:0046513, GO:1904504, GO:1904649, GO:0046511, GO:0030148, GO:0006665, GO:0006686, GO:0046512, IPR004839, IPR015424, IPR015421, IPR015422, O15269, Generic PDBTM",5,7YIY,wlidetype,O15269,UniProt,C42 H83 N O3,650.113,Z1T,"N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]tetracosanamide",CCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(CO)C(C=CCCCCCCCCCCCCC)O,7
7YJ3,Eurofins,,,,,7YJ3,Structural basis for receptor binding and broader interspecies receptor recognition of currently circulating Omicron sub-variants.,Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with human ACE2 (local refinement),HYDROLASE/VIRAL PROTEIN,"ACE2, UNQ868/PRO1885","3.4.17.23, 3.4.17","GO:0016324, GO:0031526, GO:0009986, GO:0005929, GO:0030666, GO:0005788, GO:0070062, GO:0005576, GO:0005615, GO:0016020, GO:0045121, GO:0005886, GO:0004180, GO:0004175, GO:0042802, GO:0004181, GO:0008237, GO:0008241, GO:0001618, GO:0008270, GO:0002003, GO:0003051, GO:0097746, GO:0060135, GO:0061025, GO:0070373, GO:2000272, GO:0048662, GO:0051957, GO:0060452, GO:1903598, GO:1905737, GO:2000379, GO:0019065, GO:0046813, GO:1903779, GO:0042127, GO:0001817, GO:0050727, GO:0003081, GO:0022898, GO:0019229, GO:0015827, GO:0046718, GO:0019058, IPR031588, IPR001548, Q9BYF1",1,7YJ3,mutant,Q9BYF1,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,4
7YM8,,,,,,7YM8,Structural basis of alpha 1A -adrenergic receptor activation and recognition by an extracellular nanobody.,Cryo-EM structure of Nb29-alpha1AAR-miniGsq complex bound to oxymetazoline,MEMBRANE PROTEIN,,,,1,7YM8,wlidetype,,,C16 H24 N2 O,260.375,J5C,Oxymetazoline,Cc1cc(c(c(c1CC2=NCCN2)C)O)C(C)(C)C,4
7YM8,,,,,,7YM8,Structural basis of alpha 1A -adrenergic receptor activation and recognition by an extracellular nanobody.,Cryo-EM structure of Nb29-alpha1AAR-miniGsq complex bound to oxymetazoline,MEMBRANE PROTEIN,,,,2,7YM8,wlidetype,,,C31 H50 O4,486.726,Y01,CHOLESTEROL HEMISUCCINATE,CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)CCC(=O)O)C)C,5
7YMH,,,,,,7YMH,Structural basis of alpha 1A -adrenergic receptor activation and recognition by an extracellular nanobody.,Cryo-EM structure of Nb29-alpha1AAR-miniGsq complex bound to noradrenaline,MEMBRANE PROTEIN,,,,1,7YMH,wlidetype,,,C8 H12 N O3,170.186,E5E,Noradrenaline,c1cc(c(cc1C(C[NH3+])O)O)O,4
7YMJ,,,,,,7YMJ,Structural basis of alpha 1A -adrenergic receptor activation and recognition by an extracellular nanobody.,Cryo-EM structure of alpha1AAR-Nb6 complex bound to tamsulosin,MEMBRANE PROTEIN,,,,1,7YMJ,wlidetype,,,C20 H28 N2 O5 S,408.512,JGX,Tamsulosin,CCOc1ccccc1OCCNC(C)Cc2ccc(c(c2)S(=O)(=O)N)OC,3
7YW3,,,,,,7YW3,Structural and biochemical insights into the molecular mechanism of TRPT1 for nucleic acid ADP-ribosylation.,Crystal structure of tRNA 2'-phosphotransferase from Homo sapiens,TRANSFERASE,TRPT1,2.7.1.160,"GO:0000215, GO:0045859, GO:0006388, IPR002745, IPR042081, IPR042080, Q86TN4",1,7YW3,wlidetype,Q86TN4,UniProt,C15 H24 N5 O17 P3,639.296,HQG,"[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{R},5~{R})-3,4-bis(oxidanyl)-5-phosphonooxy-oxolan-2-yl]methyl hydrogen phosphate",c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OCC4C(C(C(O4)OP(=O)(O)O)O)O)O)O)N,2
8DMS,,,,,,8DMS,Structure of Legionella pneumophila macrodomain MavL in complex with ubiquitin vinyl methyl ester soaked with ADP-ribose,Crystal structure of Legionella pneumophila macrodomain MavL in complex with ubiquitin vinyl methyl ester soaked with ADP-ribose,ANTITOXIN,,,,1,8DMS,wlidetype,Q5ZSJ1,UniProt,C15 H23 N5 O14 P2,559.316,AR6,"[(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE",c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OCC4C(C(C(O4)O)O)O)O)O)N,3
8DYJ,,,,,,8DYJ,Allosteric control of metal redox state regulates coenzyme B12 repair,Crystal structure of human methylmalonyl-CoA mutase in complex with ADP and cob(II)alamin,ISOMERASE,"MMUT, MUT",5.4.99.2,"GO:0005737, GO:0005759, GO:0005739, GO:0031419, GO:0003924, GO:0042802, GO:0046872, GO:0004494, GO:0072341, GO:0042803, GO:0050667, GO:0043547, GO:0009791, GO:0019678, IPR006159, IPR016176, IPR006158, IPR036724, IPR006099, IPR006098, P22033",1,8DYJ,wlidetype,P22033,UniProt,C62 H89 Co N13 O14 P,1330.356,B12,COBALAMIN,Cc1cc2c(cc1C)n(cn2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C7=[N]6[Co+2]89[N]5=C4C(=C1[NH]8C(=CC2=[N]9C(=C7C)C(C2CCC(=O)N)(C)CC(=O)N)C(C1CCC(=O)N)(C)C)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O,2
8DYJ,,,,,,8DYJ,Allosteric control of metal redox state regulates coenzyme B12 repair,Crystal structure of human methylmalonyl-CoA mutase in complex with ADP and cob(II)alamin,ISOMERASE,"MMUT, MUT",5.4.99.2,"GO:0005737, GO:0005759, GO:0005739, GO:0031419, GO:0003924, GO:0042802, GO:0046872, GO:0004494, GO:0072341, GO:0042803, GO:0050667, GO:0043547, GO:0009791, GO:0019678, IPR006159, IPR016176, IPR006158, IPR036724, IPR006099, IPR006098, P22033",1,8DYJ,wlidetype,P22033,UniProt,C10 H15 N5 O10 P2,427.201,ADP,ADENOSINE-5'-DIPHOSPHATE,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N,3
8DYL,,,,,,8DYL,Allosteric control of metal redox state regulates coenzyme B12 repair,Crystal structure of human methylmalonyl-CoA mutase bound to aquocobalamin,ISOMERASE,"MMUT, MUT",5.4.99.2,"GO:0005737, GO:0005759, GO:0005739, GO:0031419, GO:0003924, GO:0042802, GO:0046872, GO:0004494, GO:0072341, GO:0042803, GO:0050667, GO:0043547, GO:0009791, GO:0019678, IPR006159, IPR016176, IPR006158, IPR036724, IPR006099, IPR006098, P22033",1,8DYL,wlidetype,P22033,UniProt,C62 H89 Co N13 O14 P,1330.356,B12,COBALAMIN,Cc1cc2c(cc1C)n(cn2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C7=[N]6[Co+2]89[N]5=C4C(=C1[NH]8C(=CC2=[N]9C(=C7C)C(C2CCC(=O)N)(C)CC(=O)N)C(C1CCC(=O)N)(C)C)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O,2
8F0M,,,,,,8F0M,Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors.,Monobody 12D5 bound to KRAS(G12D),SIGNALING PROTEIN/DE NOVO PROTEIN,"KRAS, KRAS2, RASK2",3.6.5.2,"GO:0005737, GO:0005829, GO:0005789, GO:0031234, GO:0005925, GO:0000139, GO:0016020, GO:0005741, GO:0005886, GO:0003925, GO:0019003, GO:0005525, GO:0003924, GO:0042802, GO:0044877, GO:0030036, GO:0038002, GO:0060441, GO:0021897, GO:0014009, GO:0048873, GO:0000165, GO:0030857, GO:0043524, GO:0051402, GO:0008284, GO:0010628, GO:0060252, GO:0001934, GO:0035022, GO:0016601, GO:0007265, GO:0048169, GO:0031647, GO:0032228, GO:0035914, GO:0051146, GO:0060509, GO:0008542, IPR027417, IPR005225, IPR001806, IPR020849",2,8F0M,mutant,P01116-2,UniProt,C10 H15 N5 O11 P2,443.201,GDP,GUANOSINE-5'-DIPHOSPHATE,c1nc2c(n1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N,4
8F0M,,,,,,8F0M,Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors.,Monobody 12D5 bound to KRAS(G12D),SIGNALING PROTEIN/DE NOVO PROTEIN,"KRAS, KRAS2, RASK2",3.6.5.2,"GO:0005737, GO:0005829, GO:0005789, GO:0031234, GO:0005925, GO:0000139, GO:0016020, GO:0005741, GO:0005886, GO:0003925, GO:0019003, GO:0005525, GO:0003924, GO:0042802, GO:0044877, GO:0030036, GO:0038002, GO:0060441, GO:0021897, GO:0014009, GO:0048873, GO:0000165, GO:0030857, GO:0043524, GO:0051402, GO:0008284, GO:0010628, GO:0060252, GO:0001934, GO:0035022, GO:0016601, GO:0007265, GO:0048169, GO:0031647, GO:0032228, GO:0035914, GO:0051146, GO:0060509, GO:0008542, IPR027417, IPR005225, IPR001806, IPR020849",2,8F0M,mutant,P01116-2,UniProt,C10 H16 N5 O13 P3 S,539.246,GSP,5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE,c1nc2c(n1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=S)(O)O)O)O)N=C(NC2=O)N,6
8F5F,,,,,,8F5F,Discovery of branched-chain ketoacid dehydrogenase kinase (BDK) inhibitors acting as stabilizers or destabilizers,human branched chain ketoacid dehydrogenase kinase in complex with inhibitors,"SIGNALING PROTEIN,TRANSFERASE/INHIBITOR",BCKDK,2.7.11.4,"GO:0005947, GO:0005759, GO:0005739, GO:0047323, GO:0005524, GO:0016301, GO:0004674, GO:0004740, GO:0009063, GO:0009083, GO:0045763, GO:0016310, GO:0006468, GO:0010906, IPR036784, IPR018955, IPR039028, IPR003594, IPR036890, IPR005467, IPR004358, O14874",1,8F5F,wlidetype,O14874,UniProt,C21 H20 N2 O3 S,380.46,XGG,"(2P)-2-[(4P)-4-{6-[(1-ethylcyclopropyl)methoxy]pyridin-3-yl}-1,3-thiazol-2-yl]benzoic acid",CCC1(CC1)COc2ccc(cn2)c3csc(n3)c4ccccc4C(=O)O,4
8F5J,,,,,,8F5J,Discovery of branched-chain ketoacid dehydrogenase kinase (BDK) inhibitors acting as stabilizers or destabilizers,human branched chain ketoacid dehydrogenase kinase in complex with inhibitors,"SIGNALING PROTEIN,TRANSFERASE/INHIBITOR",BCKDK,2.7.11.4,"GO:0005947, GO:0005759, GO:0005739, GO:0047323, GO:0005524, GO:0016301, GO:0004674, GO:0004740, GO:0009063, GO:0009083, GO:0045763, GO:0016310, GO:0006468, GO:0010906, IPR036784, IPR018955, IPR039028, IPR003594, IPR036890, IPR005467, IPR004358, O14874",1,8F5J,wlidetype,O14874,UniProt,C7 H2 Cl F O2 S2,236.671,XER,"3-chloro-5-fluorothieno[3,2-b]thiophene-2-carboxylic acid",c1c2c(c(c(s2)C(=O)O)Cl)sc1F,5
8F5S,,,,,,8F5S,Discovery of branched-chain ketoacid dehydrogenase kinase (BDK) inhibitors acting as stabilizers or destabilizers,human branched chain ketoacid dehydrogenase kinase in complex with inhibitors,"SIGNALING PROTEIN,TRANSFERASE/INHIBITOR",BCKDK,2.7.11.4,"GO:0005947, GO:0005759, GO:0005739, GO:0047323, GO:0005524, GO:0016301, GO:0004674, GO:0004740, GO:0009063, GO:0009083, GO:0045763, GO:0016310, GO:0006468, GO:0010906, IPR036784, IPR018955, IPR039028, IPR003594, IPR036890, IPR005467, IPR004358, O14874",1,8F5S,wlidetype,O14874,UniProt,C17 H13 N O2 S,295.356,XGT,"(2M)-2-[2-(4-methylphenyl)-1,3-thiazol-4-yl]benzoic acid",Cc1ccc(cc1)c2nc(cs2)c3ccccc3C(=O)O,5
8F7A,,,,,,8F7A,Mechanism of RanGTP priming H2A-H2B release from Kap114 in an atypical RanGTP?줜ap114?줙2A-H2B complex.,Cryo-EM structure of Importin-9 bound to RanGTP,PROTEIN TRANSPORT,"GSP1, CNR1, CST17, YLR293C, L8003.19",,"GO:0005737, GO:0005829, GO:0005634, GO:0005525, GO:0003924, GO:0000467, GO:0006997, GO:0016973, GO:0006606, GO:1901987, GO:0046822, GO:0000054, IPR027417, IPR002041, IPR005225, IPR001806",2,8F7A,wlidetype,P32835,UniProt,C10 H16 N5 O14 P3,523.18,GTP,GUANOSINE-5'-TRIPHOSPHATE,c1nc2c(n1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N,4
8FSJ,,,,,,8FSJ,Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies.,"Cryo-EM structure of engineered hepatitis C virus E1E2 ectodomain in complex with antibodies AR4A, HEPC74, and IGH520",VIRAL PROTEIN,,,"GO:0005737, GO:0044167, GO:0044186, GO:0044191, GO:0042025, GO:0005811, GO:0016020, GO:1990904, GO:0019031, GO:0019013, GO:0055036, GO:0005198, GO:0075512, GO:0019049, IPR002521, IPR002519, IPR002531",1,8FSJ,wlidetype,A0A2P0NE15,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,9
8FW5,,,,,,8FW5,Structure of the Schizosaccharomyces pombe Gtr-Lam complex reveals evolutionary divergence of mTORC1-dependent amino acid sensing.,Chimeric HsGATOR1-SpGtr-SpLam complex,SIGNALING PROTEIN,"DEPDC5, KIAA0645",,"GO:0005829, GO:1990130, GO:0005765, GO:0005764, GO:0048471, GO:0005096, GO:0044877, GO:0034198, GO:0035556, GO:0032007, GO:1904262, GO:0010508, IPR000591, IPR045838, IPR027244, IPR036388, IPR036390, O75140",1,8FW5,mutant,O75140,UniProt,C10 H15 N5 O11 P2,443.201,GDP,GUANOSINE-5'-DIPHOSPHATE,c1nc2c(n1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N,10
8G1A,,,,,,8G1A,Cannabidiol inhibits Na v channels through two distinct binding sites.,Cryo-EM structure of Nav1.7 with CBD,MEMBRANE PROTEIN,SCN1B,,"GO:0005576, GO:0014704, GO:0033268, GO:0043204, GO:0005886, GO:0030315, GO:0001518, GO:0019871, GO:0017080, GO:0044325, GO:0005244, GO:0005248, GO:0086006, GO:0086062, GO:0007411, GO:0061337, GO:0086002, GO:0060048, GO:0007155, GO:0021966, GO:0040011, GO:0051899, GO:0086012, GO:0086047, GO:0019227, GO:0010976, GO:0010765, GO:0060371, GO:0086091, GO:2000649, GO:0060307, GO:0035725, IPR036179, IPR013783, IPR013106, IPR027098, IPR044568, Q07699, Generic PDBTM",2,8G1A,wlidetype,Q07699,UniProt,C21 H30 O2,314.462,P0T,cannabidiol,CCCCCc1cc(c(c(c1)O)C2C=C(CCC2C(=C)C)C)O,6
8G1P,,,,,,8G1P,Affinity and cooperativity modulate ternary complex formation to drive targeted protein degradation.,Co-crystal structure of Compound 11 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:ElonginB,GENE REGULATION,"ELOC, TCEB1",,"GO:0031462, GO:0031466, GO:0005829, GO:0070449, GO:0005654, GO:0030674, GO:0001222, GO:0016567, GO:0006357, GO:0006367, GO:0006511, IPR039948, IPR001232, IPR011333, IPR016073, Q15369",2,8G1P,wlidetype,Q15369,UniProt,C49 H58 F N9 O6 S,920.105,FWZ,"(2~{S},4~{R})-~{N}-[[2-[2-[4-[[4-[3-azanyl-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazin-1-yl]methyl]phenyl]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide",Cc1c(scn1)c2ccc(c(c2)OCCc3ccc(cc3)CN4CCN(CC4)c5cc(nnc5N)c6ccccc6O)CNC(=O)C7CC(CN7C(=O)C(C(C)(C)C)NC(=O)C8(CC8)F)O,6
8G4M,,,,,,8G4M,HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide.,Vaccine-elicited human antibody 2C06 in complex with HIV-1 envelope trimer BG505 DS-SOSIP,ANTIVIRAL PROTEIN,env,,"GO:0044175, GO:0020002, GO:0005886, GO:0019031, GO:0055036, GO:0042802, GO:0005198, GO:0075512, GO:0039654, GO:0019064, GO:1903905, GO:1903908, GO:1903911, GO:0019082, GO:0019062, IPR036377, IPR037527, IPR000328, IPR000777",1,8G4M,mutant,Q2N0S6,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,10
8G4T,,,,,,8G4T,HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide.,Vaccine-elicited human antibody 2C09 in complex with HIV-1 envelope trimer BG505 DS-SOSIP,VIRAL PROTEIN/IMMUNE SYSTEM,env,,"GO:0044175, GO:0020002, GO:0005886, GO:0019031, GO:0055036, GO:0005198, GO:0075512, GO:0039654, GO:0019064, GO:1903905, GO:1903908, GO:1903911, GO:0019082, GO:0019062, IPR036377, IPR037527, IPR000328, IPR000777",1,8G4T,mutant,Q2N0S7,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,9
8GH7,,,,,,8GH7,Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist.,142D6 bound to BIR3-XIAP,SIGNALING PROTEIN/INHIBITOR,"XIAP, API3, BIRC4, IAP3",2.3.2.27,"GO:0005737, GO:0005829, GO:0005654, GO:0005634, GO:0005876, GO:0043027, GO:0042802, GO:0046872, GO:0120283, GO:0061630, GO:0004842, GO:0006974, GO:0055070, GO:0097340, GO:1990001, GO:0043066, GO:0043154, GO:0010804, GO:0051402, GO:0090263, GO:0046330, GO:1902530, GO:0031398, GO:0060785, GO:0042981, GO:0030510, GO:0051726, GO:0042127, GO:0050727, GO:0045088, GO:0070424, GO:0016055, IPR001370, IPR011029, IPR042579, IPR001841, P98170",2,8GH7,wlidetype,P98170,UniProt,C14 H30 O7,310.384,7PE,2-(2-(2-(2-(2-(2-ETHOXYETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHANOL,CCOCCOCCOCCOCCOCCOCCO,4
8GK3,,,,,,8GK3,Human Cytochrome P450 3A7 Binding Four Copies of Its Native Substrate Dehydroepiandrosterone 3-Sulfate.,Cytochrome P450 3A7 in complex with Dehydroepiandrosterone sulfate,OXIDOREDUCTASE,CYP3A7,1.14.14.1,"GO:0005789, GO:0062183, GO:0070330, GO:0101020, GO:0101021, GO:0020037, GO:0005506, GO:0004497, GO:0019825, GO:0008401, GO:0008395, GO:0008210, GO:0002933, GO:0070989, GO:0042573, GO:0042572, GO:0006694, GO:0008202, GO:0006805, IPR001128, IPR017972, IPR008072, IPR002402, IPR036396, P24462",1,8GK3,wlidetype,P24462,UniProt,C34 H32 Fe N4 O4,616.487,HEM,PROTOPORPHYRIN IX CONTAINING FE,Cc1c2n3c(c1CCC(=O)O)C=C4C(=C(C5=[N]4[Fe]36[N]7=C(C=C8N6C(=C5)C(=C8C)C=C)C(=C(C7=C2)C)C=C)C)CCC(=O)O,2
8GK3,,,,,,8GK3,Human Cytochrome P450 3A7 Binding Four Copies of Its Native Substrate Dehydroepiandrosterone 3-Sulfate.,Cytochrome P450 3A7 in complex with Dehydroepiandrosterone sulfate,OXIDOREDUCTASE,CYP3A7,1.14.14.1,"GO:0005789, GO:0062183, GO:0070330, GO:0101020, GO:0101021, GO:0020037, GO:0005506, GO:0004497, GO:0019825, GO:0008401, GO:0008395, GO:0008210, GO:0002933, GO:0070989, GO:0042573, GO:0042572, GO:0006694, GO:0008202, GO:0006805, IPR001128, IPR017972, IPR008072, IPR002402, IPR036396, P24462",2,8GK3,wlidetype,P24462,UniProt,C19 H28 O5 S,368.488,ZQK,Dehydroepiandrosterone sulfate,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)OS(=O)(=O)O)C,3
8GQU,,,,,,8GQU,Cryo-EM structures of ClC-2 chloride channel reveal the blocking mechanism of its specific inhibitor AK-42.,AK-42 inhibitor binding human ClC-2 TMD,MEMBRANE PROTEIN,CLCN2,,"GO:0034707, GO:0030425, GO:0043204, GO:0005886, GO:0005247, GO:0090425, GO:0060689, GO:0006821, GO:0030324, GO:0032347, GO:0034765, GO:0060041, IPR046342, IPR002244, IPR014743, IPR001807, P51788, Generic PDBTM",1,8GQU,wlidetype,P51788,UniProt,C19 H14 Cl2 N2 O3,389.232,GH6,"2-[[2,6-bis(chloranyl)-3-phenylmethoxy-phenyl]amino]pyridine-3-carboxylic acid",c1ccc(cc1)COc2ccc(c(c2Cl)Nc3c(cccn3)C(=O)O)Cl,2
8GTO,,,,,,8GTO,Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants.,cryo-EM structure of Omicron BA.5 S protein in complex with XGv282,VIRAL PROTEIN/IMMUNE SYSTEM,"S, 2",,"GO:0044173, GO:0020002, GO:0016020, GO:0019031, GO:0055036, GO:0046789, GO:0042802, GO:0075509, GO:0039654, GO:0019064, GO:0061025, GO:0046598, GO:0019065, GO:0046813, GO:0039587, GO:0039502, GO:0046718, GO:0019058, IPR032500, IPR042578, IPR043607, IPR043473, IPR043002, IPR044341, IPR018548, IPR044366, IPR036326, IPR002552, IPR044873, IPR044874, P0DTC2",1,8GTO,mutant,P0DTC2,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,5
8GTP,,,,,,8GTP,Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants.,cryo-EM structure of Omicron BA.5 S protein in complex with XGv289,VIRAL PROTEIN/IMMUNE SYSTEM,,,,2,8GTP,mutant,,,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,5
8GTQ,,,,,,8GTQ,Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants.,cryo-EM structure of Omicron BA.5 S protein in complex with S2L20,VIRAL PROTEIN/IMMUNE SYSTEM,"S, 2",,"GO:0044173, GO:0020002, GO:0016020, GO:0019031, GO:0055036, GO:0046789, GO:0042802, GO:0075509, GO:0039654, GO:0019064, GO:0061025, GO:0046598, GO:0019065, GO:0046813, GO:0039587, GO:0039502, GO:0046718, GO:0019058, IPR032500, IPR042578, IPR043607, IPR043473, IPR043002, IPR044341, IPR018548, IPR044366, IPR036326, IPR002552, IPR044873, IPR044874, P0DTC2",1,8GTQ,mutant,P0DTC2,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,6
8GZV,,,,,,8GZV,Structures of a FtsZ single protofilament and a double-helical tube in complex with a monobody.,Klebsiella pneumoniae FtsZ complexed with monobody (P212121),CELL CYCLE,"ftsZ, B5L96_26660, BL124_00027905, BN49_4241, DN601_04890, EAO17_18285, FXN67_14780, G7Z27_22770, GJJ08_022520, GJJ18_04480, GJJ26_021835, GNE24_10045, HV479_18765, NCTC11679_04745, NCTC13465_04463, NCTC3279_00274, NCTC5052_02872, NCTC9128_05382, NCTC9140_01897, NCTC9637_05610, SAMEA3499874_03081, SAMEA3499901_00812, SAMEA3538828_00852, SAMEA3649733_02938, SAMEA3720909_02172, SAMEA4364603_03522",,"GO:0032153, GO:0005737, GO:0005525, GO:0003924, GO:0000917, GO:0043093, GO:0051258, IPR000158, IPR020805, IPR045061, IPR024757, IPR008280, IPR037103, IPR018316, IPR036525, IPR003008",1,8GZV,wlidetype,W9BCK7,UniProt,C10 H15 N5 O11 P2,443.201,GDP,GUANOSINE-5'-DIPHOSPHATE,c1nc2c(n1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N,3
8GZW,,,,,,8GZW,Structures of a FtsZ single protofilament and a double-helical tube in complex with a monobody.,Klebsiella pneumoniae FtsZ complexed with monobody (P21),CELL CYCLE,"ftsZ, B5L96_26660, BL124_00027905, BN49_4241, DN601_04890, EAO17_18285, FXN67_14780, G7Z27_22770, GJJ08_022520, GJJ18_04480, GJJ26_021835, GNE24_10045, HV479_18765, NCTC11679_04745, NCTC13465_04463, NCTC3279_00274, NCTC5052_02872, NCTC9128_05382, NCTC9140_01897, NCTC9637_05610, SAMEA3499874_03081, SAMEA3499901_00812, SAMEA3538828_00852, SAMEA3649733_02938, SAMEA3720909_02172, SAMEA4364603_03522",,"GO:0032153, GO:0005737, GO:0005525, GO:0003924, GO:0000917, GO:0043093, GO:0051258, IPR000158, IPR020805, IPR045061, IPR024757, IPR008280, IPR037103, IPR018316, IPR036525, IPR003008",1,8GZW,wlidetype,W9BCK7,UniProt,C10 H15 N5 O11 P2,443.201,GDP,GUANOSINE-5'-DIPHOSPHATE,c1nc2c(n1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N,3
8GZX,,,,,,8GZX,Structures of a FtsZ single protofilament and a double-helical tube in complex with a monobody.,Escherichia coli FtsZ complexed with monobody (P212121),CELL CYCLE,"ftsZ, DNQ45_06620",,"GO:0032153, GO:0005737, GO:0005525, GO:0003924, GO:0000917, GO:0043093, GO:0051258, IPR000158, IPR020805, IPR045061, IPR024757, IPR008280, IPR037103, IPR018316, IPR036525, IPR003008",1,8GZX,wlidetype,A0A2W6PFK5,UniProt,C10 H15 N5 O11 P2,443.201,GDP,GUANOSINE-5'-DIPHOSPHATE,c1nc2c(n1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N,3
8GZY,,,,,,8GZY,Structures of a FtsZ single protofilament and a double-helical tube in complex with a monobody.,Escherichia coli FtsZ complexed with monobody (P21),CELL CYCLE,"ftsZ, DNQ45_06620",,"GO:0032153, GO:0005737, GO:0005525, GO:0003924, GO:0000917, GO:0043093, GO:0051258, IPR000158, IPR020805, IPR045061, IPR024757, IPR008280, IPR037103, IPR018316, IPR036525, IPR003008",1,8GZY,wlidetype,A0A2W6PFK5,UniProt,C10 H15 N5 O11 P2,443.201,GDP,GUANOSINE-5'-DIPHOSPHATE,c1nc2c(n1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N,3
8H06,,,,,,8H06,Structural basis for receptor binding and broader interspecies receptor recognition of currently circulating Omicron sub-variants.,Cryo-EM structure of SARS-CoV-2 Omicron BA.4/5 RBD in complex with human ACE2 (local refinement),HYDROLASE/VIRAL PROTEIN,"S, 2","3.4.17.23, 3.4.17","GO:0044173, GO:0020002, GO:0016020, GO:0019031, GO:0055036, GO:0046789, GO:0042802, GO:0075509, GO:0039654, GO:0019064, GO:0061025, GO:0046598, GO:0019065, GO:0046813, GO:0039587, GO:0039502, GO:0046718, GO:0019058, IPR032500, IPR042578, IPR043607, IPR043473, IPR043002, IPR044341, IPR018548, IPR044366, IPR036326, IPR002552, IPR044873, IPR044874, P0DTC2",2,8H06,mutant,P0DTC2,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,5
8H5C,,,,,,8H5C,Structure of SARS-CoV-2 Omicron BA.2.75 RBD in complex with human ACE2,Structure of SARS-CoV-2 Omicron BA.2.75 RBD in complex with human ACE2,VIRAL PROTEIN,"S, 2","3.4.17.23, 3.4.17","GO:0044173, GO:0020002, GO:0016020, GO:0019031, GO:0055036, GO:0046789, GO:0042802, GO:0075509, GO:0039654, GO:0019064, GO:0061025, GO:0046598, GO:0019065, GO:0046813, GO:0039587, GO:0039502, GO:0046718, GO:0019058, IPR032500, IPR042578, IPR043607, IPR043473, IPR043002, IPR044341, IPR018548, IPR044366, IPR036326, IPR002552, IPR044873, IPR044874, P0DTC2",2,8H5C,mutant,P0DTC2,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,6
8HL6,,,,,,8HL6,"Structural basis for recognition and methylation of p97 by METTL21D, a valosin-containing protein lysine methyltransferase.",Crystal structure of human valosin-containing protein methyltransferase,PROTEIN BINDING,"METTL21D, VCPKMT, C14orf138",2.1.1,"GO:0005737, GO:0005829, GO:0032991, GO:0051117, GO:0016279, GO:0032780, GO:0018022, GO:0018023, GO:0006479, IPR019410, IPR029063, Q9H867",1,8HL6,wlidetype,Q9H867,UniProt,C15 H22 N6 O5 S,398.437,SAM,S-ADENOSYLMETHIONINE,C[S+](CCC(C(=O)[O-])N)CC1C(C(C(O1)n2cnc3c2ncnc3N)O)O,2
8I6K,,,,,,8I6K,Structural mechanism of dsDNA recognition by the hMNDA HIN domain: New insights into the DNA-binding model of a PYHIN protein.,Structure of hMNDA HIN with dsDNA,DNA BINDING PROTEIN/DNA,MNDA,,"GO:0035578, GO:0005829, GO:0070062, GO:0005576, GO:1904813, GO:0043231, GO:0005730, GO:0005654, GO:0003690, GO:0002218, GO:0050853, GO:0006968, GO:0006974, GO:0035458, GO:0030889, GO:0043065, GO:0032731, IPR004020, IPR011029, IPR040205, IPR004021, IPR012340, P41218",1,8I6K,wlidetype,P41218,UniProt,C4 H10 O3,106.12,PEG,DI(HYDROXYETHYL)ETHER,C(COCCO)O,3
8IUK,,,,,,8IUK,Ligand-induced activation and G protein coupling of prostaglandin F 2 alpha receptor.,Cryo-EM structure of the PGF2-alpha-bound human PTGFR-Gq complex,MEMBRANE PROTEIN,,,,1,8IUK,wlidetype,P62873,UniProt,C20 H34 O5,354.481,UGU,"(Z)-7-[(1R,2R,3R,5S)-3,5-bis(oxidanyl)-2-[(E,3S)-3-oxidanyloct-1-enyl]cyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O,7
8IUL,,,,,,8IUL,Ligand-induced activation and G protein coupling of prostaglandin F 2 alpha receptor.,Cryo-EM structure of the latanoprost-bound human PTGFR-Gq complex,MEMBRANE PROTEIN,,,,1,8IUL,wlidetype,P62873,UniProt,C23 H34 O5,390.513,7WT,"Z-7-[(1R,2R,3R,5S)-3,5-bis(oxidanyl)-2-[(3R)-3-oxidanyl-5-phenyl-pentyl]cyclopentyl]hept-5-enoic acid",c1ccc(cc1)CCC(CCC2C(CC(C2CC=CCCCC(=O)O)O)O)O,6
8IUM,,,,,,8IUM,Ligand-induced activation and G protein coupling of prostaglandin F 2 alpha receptor.,Cryo-EM structure of the tafluprost acid-bound human PTGFR-Gq complex,MEMBRANE PROTEIN,,,,1,8IUM,wlidetype,P62873,UniProt,C22 H28 F2 O5,410.452,S2F,"(~{Z})-7-[(1~{R},2~{R},3~{R},5~{S})-2-[(~{E})-3,3-bis(fluoranyl)-4-phenoxy-but-1-enyl]-3,5-bis(oxidanyl)cyclopentyl]hept-5-enoic acid",c1ccc(cc1)OCC(C=CC2C(CC(C2CC=CCCCC(=O)O)O)O)(F)F,7
8ONE,,,,,,8ONE,"Identification of Regulatory Molecular ""Hot Spots"" for LH/PLOD Collagen Glycosyltransferase Activity.","Crystal Structure of full-length Human Lysyl Hydroxylase LH3 - Asp190Ser mutant - Cocrystal with Fe2+, Mn2+, UDP-Glucose",TRANSFERASE,PLOD3,"1.14.11.4, 2.4.1.50, 2.4.1.66","GO:0062023, GO:0005783, GO:0005788, GO:0005789, GO:0070062, GO:0005615, GO:0005794, GO:0005791, GO:0005802, GO:0005506, GO:0031418, GO:0050211, GO:0033823, GO:0008475, GO:0070831, GO:0030199, GO:0032963, GO:0001886, GO:0048730, GO:0046947, GO:0001701, GO:0060425, GO:0021915, GO:0017185, GO:0008104, GO:0006493, GO:0042311, IPR044861, IPR029044, IPR005123, IPR006620, IPR001006, O60568",1,8ONE,mutant,O60568,UniProt,C15 H24 N2 O17 P2,566.302,UPG,URIDINE-5'-DIPHOSPHATE-GLUCOSE,C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OC3C(C(C(C(O3)CO)O)O)O)O)O,8
8OO7,,,,,,8OO7,Hexasome-INO80 complex reveals structural basis of noncanonical nucleosome remodeling.,CryoEM Structure INO80core Hexasome complex composite model state1,DNA BINDING PROTEIN,CTHT_0006820,3.6.4.12,"GO:0031011, GO:0035267, GO:0097255, GO:0005524, GO:0016887, GO:0003678, GO:0006325, GO:0006281, IPR003593, IPR027417, IPR027238, IPR041048, IPR037938, IPR042487, IPR010339",1,8OO7,wlidetype,G0RYI5,UniProt,C10 H15 N5 O10 P2,427.201,ADP,ADENOSINE-5'-DIPHOSPHATE,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N,13
8OO7,,,,,,8OO7,Hexasome-INO80 complex reveals structural basis of noncanonical nucleosome remodeling.,CryoEM Structure INO80core Hexasome complex composite model state1,DNA BINDING PROTEIN,"H2AC6, H2AFL, HIST1H2AC",3.6.4.12,"GO:0070062, GO:0005654, GO:0000786, GO:0005634, GO:0003677, GO:0046982, GO:0030527, GO:0008285, IPR009072, IPR002119, IPR007125, IPR032454, IPR032458, Q93077",11,8OO7,wlidetype,Q93077,UniProt,Al F4,102.975,ALF,TETRAFLUOROALUMINATE ION,F[Al-](F)(F)F,14
8OO7,,,,,,8OO7,Hexasome-INO80 complex reveals structural basis of noncanonical nucleosome remodeling.,CryoEM Structure INO80core Hexasome complex composite model state1,DNA BINDING PROTEIN,"HIST1H2BC, H2BFL, HIST1H2BE, H2BFH, HIST1H2BF, H2BFG, HIST1H2BG, H2BFA, HIST1H2BI, H2BFK, H2BC4, H2BC6, H2BC7, H2BC8, H2BC10",3.6.4.12,"GO:0005829, GO:0070062, GO:0005615, GO:0005654, GO:0000786, GO:0005634, GO:0003677, GO:0042802, GO:0046982, GO:0030527, GO:0019731, GO:0061844, GO:0050830, GO:0002227, GO:0006334, IPR009072, IPR007125, IPR000558, P62807",12,8OO7,wlidetype,P62807,UniProt,C10 H16 N5 O13 P3,507.181,ATP,ADENOSINE-5'-TRIPHOSPHATE,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N,16
8OOP,,,,,,8OOP,Hexasome-INO80 complex reveals structural basis of noncanonical nucleosome remodeling.,CryoEM Structure INO80core Hexasome complex composite model state2,DNA BINDING PROTEIN,CTHT_0006820,3.6.4.12,"GO:0031011, GO:0035267, GO:0097255, GO:0005524, GO:0016887, GO:0003678, GO:0006325, GO:0006281, IPR003593, IPR027417, IPR027238, IPR041048, IPR037938, IPR042487, IPR010339",1,8OOP,wlidetype,G0RYI5,UniProt,C10 H15 N5 O10 P2,427.201,ADP,ADENOSINE-5'-DIPHOSPHATE,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N,13
8OOP,,,,,,8OOP,Hexasome-INO80 complex reveals structural basis of noncanonical nucleosome remodeling.,CryoEM Structure INO80core Hexasome complex composite model state2,DNA BINDING PROTEIN,"H2AC6, H2AFL, HIST1H2AC",3.6.4.12,"GO:0070062, GO:0005654, GO:0000786, GO:0005634, GO:0003677, GO:0046982, GO:0030527, GO:0008285, IPR009072, IPR002119, IPR007125, IPR032454, IPR032458, Q93077",11,8OOP,wlidetype,Q93077,UniProt,Al F4,102.975,ALF,TETRAFLUOROALUMINATE ION,F[Al-](F)(F)F,15
8OOP,,,,,,8OOP,Hexasome-INO80 complex reveals structural basis of noncanonical nucleosome remodeling.,CryoEM Structure INO80core Hexasome complex composite model state2,DNA BINDING PROTEIN,"HIST1H2BC, H2BFL, HIST1H2BE, H2BFH, HIST1H2BF, H2BFG, HIST1H2BG, H2BFA, HIST1H2BI, H2BFK, H2BC4, H2BC6, H2BC7, H2BC8, H2BC10",3.6.4.12,"GO:0005829, GO:0070062, GO:0005615, GO:0005654, GO:0000786, GO:0005634, GO:0003677, GO:0042802, GO:0046982, GO:0030527, GO:0019731, GO:0061844, GO:0050830, GO:0002227, GO:0006334, IPR009072, IPR007125, IPR000558, P62807",12,8OOP,wlidetype,P62807,UniProt,C10 H16 N5 O13 P3,507.181,ATP,ADENOSINE-5'-TRIPHOSPHATE,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N,16
8OOS,,,,,,8OOS,Hexasome-INO80 complex reveals structural basis of noncanonical nucleosome remodeling.,CryoEM Structure INO80core Hexasome complex ATPase-hexasome refinement state 2,DNA BINDING PROTEIN,,,,2,8OOS,wlidetype,,,Al F4,102.975,ALF,TETRAFLUOROALUMINATE ION,F[Al-](F)(F)F,10
8OOS,,,,,,8OOS,Hexasome-INO80 complex reveals structural basis of noncanonical nucleosome remodeling.,CryoEM Structure INO80core Hexasome complex ATPase-hexasome refinement state 2,DNA BINDING PROTEIN,,,,3,8OOS,wlidetype,,,C10 H15 N5 O10 P2,427.201,ADP,ADENOSINE-5'-DIPHOSPHATE,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N,8
8PIF,,,,,,8PIF,KLHDC2 - The Next Level,Fragment 12 in complex with KLHDC2,LIGASE,"KLHDC2, HCA33",,"GO:0031462, GO:0016604, GO:0031965, GO:0005654, GO:0005634, GO:1990756, GO:0043161, GO:0016567, GO:0140627, IPR015915, Q9Y2U9",1,8PIF,wlidetype,Q9Y2U9,UniProt,C6 H6 O3,126.11,YW6,2-(furan-3-yl)ethanoic acid,c1cocc1CC(=O)O,3
8S90,,,,,,8S90,Structure of human CALHM1 reveals key locations for channel regulation and blockade by ruthenium red,Cryo-EM structure of octameric human CALHM1 (I109W) in complex with ruthenium red (C1),MEMBRANE PROTEIN,"CALHM1, FAM26C",,"GO:0016323, GO:0005789, GO:0005886, GO:0005227, GO:0042802, GO:0005261, GO:0005245, GO:0005244, GO:0015867, GO:0006812, GO:0051291, GO:0051260, GO:0034765, GO:0050896, GO:0050913, GO:0050916, GO:0050917, IPR029569, Q8IU99",1,8S90,mutant,Q8IU99,UniProt,H28 N14 O2 Ru3,559.525,R2R,ruthenium(6+) azanide pentaamino(oxido)ruthenium (1/4/2),N[Ru](N)(N)(N)(N)O[Ru](N)(N)(N)(N)O[Ru](N)(N)(N)(N)N,2
8SHJ,,,,,,8SHJ,Crystal structure of the WD-repeat domain of human WDR91 in complex with MR45279,Crystal structure of the WD-repeat domain of human WDR91 in complex with MR45279,TRANSPORT PROTEIN,"WDR91, HSPC049",,"GO:0005829, GO:0031901, GO:0031313, GO:0031902, GO:0035014, GO:0045022, GO:0043551, GO:0042176, IPR015943, IPR001680, IPR036322, IPR039724, A4D1P6",1,8SHJ,wlidetype,A4D1P6,UniProt,C20 H21 Cl N2 O3,372.845,ZI8,N-[3-(4-chlorophenyl)oxetan-3-yl]-4-[(3S)-3-hydroxypyrrolidin-1-yl]benzamide,c1cc(ccc1C(=O)NC2(COC2)c3ccc(cc3)Cl)N4CCC(C4)O,2
8T55,,,,,,8T55,Co-crystal structure of the WD-repeat domain of human WDR91 in complex with MR46654,Co-crystal structure of the WD-repeat domain of human WDR91 in complex with MR46654,TRANSPORT PROTEIN,"WDR91, HSPC049",,"GO:0005829, GO:0031901, GO:0031313, GO:0031902, GO:0035014, GO:0045022, GO:0043551, GO:0042176, IPR015943, IPR001680, IPR036322, IPR039724, A4D1P6",1,8T55,wlidetype,A4D1P6,UniProt,C22 H23 Cl N2 O3,398.883,ZI3,"N-[3-(4-chlorophenyl)oxetan-3-yl]-1-propanoyl-1,2,3,4-tetrahydroquinoline-5-carboxamide",CCC(=O)N1CCCc2c1cccc2C(=O)NC3(COC3)c4ccc(cc4)Cl,2
8TBX,,,,,,8TBX,Crystal structure of human DDX1 helicase in complex with ADP,Crystal structure of human DDX1 helicase in complex with ADP,RNA BINDING PROTEIN,DDX1,3.6.4.13,"GO:0071920, GO:0005737, GO:0010494, GO:0005829, GO:0016020, GO:0005739, GO:0005654, GO:0005634, GO:1990904, GO:0072669, GO:0005524, GO:0016887, GO:0003682, GO:0003677, GO:0033677, GO:0003725, GO:0004527, GO:0004518, GO:0008143, GO:0003723, GO:0003724, GO:0003712, GO:0051607, GO:0032508, GO:0006302, GO:0045087, GO:0090305, GO:0043123, GO:0002735, GO:1903608, GO:0006446, GO:0043330, GO:0000245, GO:0006388, IPR001870, IPR043136, IPR013320, IPR011545, IPR014001, IPR001650, IPR027417, IPR014014, IPR003877, Q92499",1,8TBX,wlidetype,Q92499,UniProt,C10 H15 N5 O10 P2,427.201,ADP,ADENOSINE-5'-DIPHOSPHATE,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N,2
